Time to Onset of Response to Pitolisant for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Patients With Narcolepsy: An Analysis of Randomized, Placebo-Controlled Trials

BACKGROUND: Pitolisant is approved in the USA and Europe for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. OBJECTIVE: Analyses evaluated the time to onset of clinical response during treatment with pitolisant. METHODS: Data were obtained from two randomized, d...

Descripción completa

Detalles Bibliográficos
Autores principales: Watson, Nathaniel F., Davis, Craig W., Zarycranski, Donna, Vaughn, Ben, Dayno, Jeffrey M., Dauvilliers, Yves, Schwartz, Jean-Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642365/
https://www.ncbi.nlm.nih.gov/pubmed/34822113
http://dx.doi.org/10.1007/s40263-021-00866-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642365/
https://www.ncbi.nlm.nih.gov/pubmed/34822113
http://dx.doi.org/10.1007/s40263-021-00866-1

Ejemplares similares